Clinical trial
Efficacy and Safety of Intralesional Triamcinolone Acetonide Alone and Its Combination With 5-fluorouracil in Keloids and Hypertrophic Scars
NCT04812626 is registered in ClinicalTrials.gov with B.P. Koirala Institute of Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Intralesional Triamcinolone Acetonide Alone and Its Combination With 5-fluorouracil in Keloids and Hypertrophic Scars
- Lead sponsor
- B.P. Koirala Institute of Health Sciences
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 28, 2021
- Completion date
- September 14, 2021
- Enrollment
- 66 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
scar keloid